Blood test could spot deadly pancreatic infection earlier

NCT ID NCT06899087

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study aims to find new blood-based markers that can predict or diagnose infected pancreatic necrosis (IPN) in people with severe pancreatitis. About 20% of acute pancreatitis cases develop tissue death (necrosis), and when that tissue gets infected, the risk of death rises to 40%. Current methods often fail to distinguish infected from sterile necrosis early enough. Researchers will analyze blood samples from 45 adults with necrotizing pancreatitis to identify immune and metabolic signals that could lead to faster, more accurate diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test that helps doctors quickly tell if pancreatic necrosis is infected, guiding earlier and more effective treatment.
What could go wrong
This is an early observational study with only 45 participants, so any findings will need confirmation in larger trials. The identified markers may not prove accurate enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • University of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.